Topiramate induced bilateral angle-closure glaucoma: low dosage in a short time.

PURPOSE

The aim of this article is to create awareness among medical colleagues regarding the severe ophthalmic side effects associated with topiramate use.

METHODS

A case of severe acute bilateral angle closure glaucoma with visual blurring after oral topiramate therapy.

RESULTS

This case was successfully managed by discontinuing topiramate and by starting anti-glaucoma medication. Intraocular pressure, acute transient myopia, and anterior chamber depth were normalized.

CONCLUSIONS

It is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.